09:00 AM EDT, 10/06/2025 (MT Newswires) -- Health care stocks were edging higher pre-bell Monday, with The Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.2%.

Abivax ( ABVX ) shares were up more than 7% after the company said results from two clinical trials showed that a 50-milligram daily dose regimen of its potential moderate-to-severely active ulcerative colitis treatment obefazimod met its primary endpoint of clinical remission at week eight.